The investigation, led by attorney Juan Monteverde, focuses on the financial fairness of the transaction for those currently holding NextCure, Inc. (NASDAQ: NXTC) stock. Monteverde & Associates, which maintains offices in the Empire State Building, is encouraging investors to review the merger details to determine if the proposed ownership stake reflects the company's true market position.

Shareholders concerned about the dilution of their holdings or the overall structure of the acquisition are invited to contact the firm for a legal assessment. Monteverde & Associates, recognized in the 2025 ISS Securities Class Action Services Report, handles litigation involving securities fraud and corporate governance across U.S. courts. The firm notes that all inquiries regarding this investigation are provided at no cost to the shareholders.